MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Speech is a sensitive marker in premanifest Huntington’s disease: exploring acoustic, cognitive and fine motor performance

    A. Vogel, J. Chan, Y. Lie, J. Stout (Melbourne, Australia)

    Objective: To explore the utility of objective analysis of speech as a quantifiable clinical biomarker in premanifest HD. Background: The autosomal dominant inheritance of Huntington’s…
  • MDS Virtual Congress 2020

    A Rare Disease with Atypical Clinical And Imaging Findings: Anti Lgi-1 Encephalitis

    O. Yilmaz Kusbeci, I. Keskin, M. Gedizlioglu (Izmir, Turkey)

    Objective: We present a case that will raise awareness about the disease with atypical clinical and rich imaging findings that has benefited greatly from intensive…
  • MDS Virtual Congress 2020

    Perillyl alcohol restores mitochondrial dysfunction and abridge NLRP3 inflammasomes activation in in-vitro and in-vivo model of Parkinson’s disease

    P. Panda, S. Ahmed, V. Naidu (Kamrup, India)

    Objective: Parkinson's disease (PD) affects around 2-3% population of age greater than 65 and is the second most common neurogenerative disorder. The molecular mechanism underpinning…
  • MDS Virtual Congress 2020

    Validation of MDS-UPDRS-based score to predict conversion to freezing of gait in Parkinson’s disease

    N. D'Cruz, W. Vandenberghe, A. Nieuwboer (Leuven, Belgium)

    Objective: To validate an MDS-UPDRS component score for predicting conversion to freezing of gait in Parkinson’s disease. Background: Freezing of gait (FOG) is a debilitating…
  • MDS Virtual Congress 2020

    Treatment of hemichorea-hemiballism with valbenazine

    J. Leegwater-Kim (BURLINGTON, MA, USA)

    Objective: To describe a video-case report of hemichorea-hemiballism improved by valbenazine therapy Background: Hemichorea-hemiballism (HCHB) is an uncommon movement disorder with numerous etiologies including structural…
  • MDS Virtual Congress 2020

    Real-World Healthcare Resource Utilization in Patients with Parkinson’s Disease and Motor Fluctuations

    M. Serbin, S. Odak, C. Macahilig, N. Joshi, A. Shah, X. Ng, K. Olson, G. Liang, O. Klepitskaya, C. Yonan (San Diego, CA, USA)

    Objective: To evaluate healthcare resource utilization (HCRU) patterns in patients with Parkinson’s disease (PD) and motor fluctuations (MF) with carbidopa/levodopa (CD/LD) and other adjunctive PD…
  • MDS Virtual Congress 2020

    Trends and Racial Disparities of Palliative Care Use among Hospitalized Patients with Parkinson’s Disease

    S. Jimsheleishvili, D. Di Luca, M. Feldman, J. Margolesky, D. Shpiner, C. Singer, C. Luca (Miami, FL, USA)

    Objective: To analyze the rate of palliative care consultations among hospitalized patients with Parkinson’s Disease (PD) using the National Inpatient Sample data from 2007 to…
  • MDS Virtual Congress 2020

    Discrimination of alpha-synuclein strains and sub-strains in Synucleinopathies

    M. Shahnawaz, A. Mukherjee, S. Pritzkow, N. Dinamarca, F. Wang, P. Rabadia, C. Soto (Houston, TX, USA)

    Objective: To differentiate and characterize alpha-synuclein strains and sub-strains associated with synucleinopathies. Background: Synucleinopathies are a diverse group of neurodegenerative diseases characterized by misfolding aggregation…
  • MDS Virtual Congress 2020

    Parkinson’s disease patients at Hoehn and Yahr stage 1 show deficits in reactive but not proactive inhibitory control

    V. Di Caprio, N. Modugno, C. Mancini, E. Olivola, G. Mirabella (Pozzilli, Italy)

    Objective: We wanted to assess whether i) Parkinson’s disease (PD) patients at Hoehn and Yahr (HY) stage 1 show a global or a selective impairment…
  • MDS Virtual Congress 2020

    Baseline Predictors of Constipation and Probable Rapid Eye Movement Sleep Behavior Disorder (pRBD) for Cognitive Impairment After 5 Years of Parkinson’s Disease (PD) Diagnosis in the Parkinson’s Progression Markers Initiative Cohort (PPMI)

    W.L Kong, Y. Huang, E. Qian, M. Morris (Sydney, Australia)

    Objective: Cognitive impairment is linked to morbidity and mortality in patients with PD, this study aims to investigate whether the presence of constipation and RBD…
  • « Previous Page
  • 1
  • …
  • 75
  • 76
  • 77
  • 78
  • 79
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley